EXOZYMES INC. (EXOZ) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US4618741098
EXOZYMES INC. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -9.72 m USD |
| EBIT | -9.26 m USD |
| Net income | -9.16 m USD |
| Diluted EPS – continuing operations | -1.09 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About EXOZYMES INC.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
More stocks
- Hanchem Co,. Ltd. (457370.KQ)
- Laredo Oil, Inc. (LRDC)
- ELUTIA INC. (ELUT)
- Biomea Fusion, Inc. (BMEA)
- Serina Therapeutics, Inc. (SER)
- Organto Foods Incorporated (OGO.V)
- Sino Green Land Corp. (SGLA)
- Fair Value REIT-AG (FVI.F)
- Model Solution Co., Ltd. (417970.KQ)
- Luminescence Technology Corp. (6729.TWO)
- Cellid Co. Ltd (299660.KQ)
- Tongyang Pile Inc (228340.KQ)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.